HUMAN IMMUNODEFICIENCY VIRUS (HIV)

This study is testing whether adding a medication called fostemsavir to standard HIV treatment can lower the risk of heart disease in people whose HIV is already well-controlled. Researchers will compare heart scans, physical tests, and blood markers over two years between 150 pa…

This study is testing a new peer-led support program called TLC, designed by and for transgender women, to help reduce substance use problems and lower HIV risk. The program uses mindfulness and acceptance techniques to help participants cope with stigma and stress. Researchers a…

This study is testing two different smartphone apps designed to help people living with HIV quit smoking. All participants will receive nicotine patches and gum, plus one of the apps to use for six months. Researchers want to see which app approach works better to help this speci…

This study is testing whether a new monthly oral pill (MK-8527) works better than the current standard daily pill to prevent HIV infection in women. It will involve about 4,580 HIV-negative women who are sexually active. The research will compare how well each option prevents HIV…

This study is testing whether a new monthly oral pill called MK-8527 works as well as or better than standard daily PrEP medication to prevent HIV infection. The trial will involve 4,390 HIV-negative adults at risk of HIV exposure. Researchers will compare how effective the month…

This study aims to understand how chronic stress affects brain activity and immune system function in people living with HIV who also use stimulants like methamphetamine or cocaine. Researchers will test whether a 5-session online program focused on positive emotions can reduce s…

This study aims to understand how adults in France choose to get voluntary HIV tests. Researchers will survey 1,000 participants about whether they use doctor's referrals, testing centers, labs, rapid tests, or self-test kits. The goal is to gather information to help improve pub…